Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Free Cash Flow (2023 - 2025)

SeaStar Medical Holding's Free Cash Flow history spans 3 years, with the latest figure at -$4.1 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 12.76% year-over-year to -$4.1 million; the TTM value through Dec 2025 reached -$13.6 million, up 15.04%, while the annual FY2025 figure was -$13.6 million, 15.04% up from the prior year.
  • Free Cash Flow reached -$4.1 million in Q4 2025 per ICUCW's latest filing, down from -$3.8 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$1.3 million in Q3 2023 to a low of -$5.0 million in Q3 2024.
  • Average Free Cash Flow over 3 years is -$3.3 million, with a median of -$3.2 million recorded in 2024.
  • Peak YoY movement for Free Cash Flow: crashed 274.12% in 2024, then grew 23.91% in 2025.
  • A 3-year view of Free Cash Flow shows it stood at -$4.5 million in 2023, then decreased by 4.64% to -$4.7 million in 2024, then rose by 12.76% to -$4.1 million in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Free Cash Flow are -$4.1 million (Q4 2025), -$3.8 million (Q3 2025), and -$3.0 million (Q2 2025).